CARDIEX LIMITED - Announcements

11.1%

3.2¢

Market Cap $17.60M

Technology Scientific & Technical Instruments

CardieX Limited is an Australia-based digital health technology company. The Company... CardieX Limited is an Australia-based digital health technology company. The Company develops and markets noninvasive patient monitoring technologies for assessing cardiovascular health. It specializes in the development of biomarkers and digital solutions for large-scale cardiovascular health disorders. Its solutions are designed to be deployed at point-of-care for arterial health screening, and as part of a remote patient monitoring regimen to extend care and enhance cardiovascular health outcomes. Its suite of products includes medical and home health devices and digital solutions for hypertension, cardiovascular disease, and other vascular health disorders all based on the Company’s SphygmoCor vascular biomarker technology. Its products include CONNEQT Pulse, SphygmoCor XCEL, and Oscar 2 Ambulatory Blood Pressure Monitor. CONNEQT Pulse measures both brachial and central blood pressures alongside a suite of vascular biomarkers to provide unparalleled insights into vascular health.More

Actinogen Medical (ASX:ACW) reaches 100th participant milestone in Alzheimer’s Disease Trial & confirms interim analysis timeline.

Announcements

Filter Results

All Price Sensitive Only

CDX	Appointment of new Director		14/10/15	28.59KB	Share
CDX	Annual Report to shareholders		13/10/15	12.61MB	Share
CDX	Appendix 4G/Corporate Governance Statement		13/10/15	719.51KB	Share
CDX	Notice of Annual General Meeting/Proxy Form		13/10/15	242.07KB	Share
CDX	Appendix 3B		16/09/15	133.57KB	Share
CDX	Ceasing to be a substantial holder from OCP		21/08/15	114.04KB	Share
CDX	App 4E / Full Year Statutory Accounts	PRICE SENSITIVE	20/08/15	723.79KB	Share
CDX	Change in substantial holding		11/08/15	185.95KB	Share
CDX	Change of Director's Interest Notice x 4		29/07/15	121.33KB	Share
CDX	American Heart Assoc new statement on arterial stiffness		28/07/15	29.2KB	Share
CDX	Top 20 securityholders		23/07/15	27.81KB	Share
CDX	Appendix 3B		23/07/15	135.91KB	Share
CDX	Rights issue update		21/07/15	25.02KB	Share
CDX	Notice of despatch of rights issue documents		02/07/15	31.17KB	Share
CDX	Rights offer booklet	PRICE SENSITIVE	01/07/15	105.91KB	Share
CDX	Becoming a substantial holder from AEF		25/06/15	381.49KB	Share
CDX	Letter to shareholders - rights issue		24/06/15	44.74KB	Share
CDX	Appendix 3B		23/06/15	134.64KB	Share
CDX	Cleansing notice		23/06/15	73.89KB	Share
CDX	Letter to optionholders - rights issue		23/06/15	84.98KB	Share
CDX	Appendix 3B - rights		18/06/15	153.89KB	Share
CDX	Successful share placement and rights issue	PRICE SENSITIVE	17/06/15	33.54KB	Share
CDX	Trading Halt	PRICE SENSITIVE	15/06/15	64.29KB	Share
CDX	Expert panel guidelines for central waveform analysis	PRICE SENSITIVE	28/05/15	38.31KB	Share
CDX	Investor presentation		04/05/15	653.03KB	Share
CDX	CE Mark for Oscar 2 with SphygmoCor Inside	PRICE SENSITIVE	04/05/15	55.09KB	Share
CDX	Appendix 3B		31/03/15	146.79KB	Share
CDX	Appendix 3B		24/03/15	147.09KB	Share
CDX	Appendix 3B		18/03/15	146.65KB	Share
CDX	Change in substantial holding		13/03/15	207.96KB	Share
CDX	Appendix 3B		12/03/15	146.69KB	Share
CDX	Teleconference details		10/03/15	40.77KB	Share
CDX	AMA accepts recommendation for category 1 CPT code	PRICE SENSITIVE	10/03/15	50.31KB	Share
CDX	AtCor reports first half profit		23/02/15	34.09KB	Share
CDX	Half Yearly Report and Accounts	PRICE SENSITIVE	23/02/15	279.99KB	Share
CDX	Tax refund	PRICE SENSITIVE	22/01/15	24.53KB	Share
CDX +OCP	Becoming a substantial holder from OCP		04/12/14	267.68KB	Share
CDX +OCP	Becoming a substantial holder from OCP		04/12/14	263.33KB	Share
CDX	Appendix 3B		03/12/14	146.87KB	Share
CDX	Cleansing statement		28/11/14	27.79KB	Share
CDX +OCP	Successful share placement	PRICE SENSITIVE	28/11/14	26.17KB	Share
CDX	Trading Halt	PRICE SENSITIVE	27/11/14	51.72KB	Share
CDX	Results of Meeting		31/10/14	34.31KB	Share
CDX	Chairmans address to AGM		31/10/14	89.84KB	Share
CDX	Investor presentation		24/10/14	986.04KB	Share
CDX	SphygmoCor selected for US publicly funded study	PRICE SENSITIVE	07/10/14	26.13KB	Share
CDX	Annual Report to shareholders		30/09/14	1.13MB	Share
CDX	Notice of Annual General Meeting/Proxy Form		30/09/14	641.19KB	Share
CDX	Change in substantial holding		12/09/14	159.69KB	Share
CDX	SphygmoCor selected for French Alzheimers trial	PRICE SENSITIVE	03/09/14	32.26KB	Share
CDX	App 4E / Full Year Statutory Accounts	PRICE SENSITIVE	28/08/14	1.16MB	Share
CDX	Market update	PRICE SENSITIVE	03/07/14	32.4KB	Share
CDX	AtCor and SunTech launch innovative ABPM for Central BP	PRICE SENSITIVE	18/06/14	48.99KB	Share
CDX	First SphygmoCor sales in China	PRICE SENSITIVE	02/06/14	29.56KB	Share
CDX	Investor presentation		01/05/14	1.44MB	Share
CDX	Patent grant in USA	PRICE SENSITIVE	16/04/14	35.76KB	Share
CDX	Study shows improved outcomes from SphygmoCor guided therapy	PRICE SENSITIVE	03/04/14	39.06KB	Share
CDX	Change in substantial holding		07/03/14	85.85KB	Share
CDX	1H FY2014 results		20/02/14	33.37KB	Share
CDX	Half Yearly Report and Accounts	PRICE SENSITIVE	20/02/14	346.08KB	Share
CDX	SphygmoCor XCEL approved for sale in Canada	PRICE SENSITIVE	30/01/14	104.91KB	Share
CDX +ALF	Ceasing to be a substantial holder from ALF		14/01/14	16.57KB	Share
CDX	SphygmoCor XCEL approved for sale in China	PRICE SENSITIVE	14/01/14	108.08KB	Share
CDX	Market update	PRICE SENSITIVE	09/01/14	157.53KB	Share
CDX	Appendix 3B		08/01/14	328.92KB	Share
CDX +ALF	Change in substantial holding from ALF		06/01/14	43.93KB	Share
CDX	Meta-analysis finds improved cardiovascular risk prediction		12/12/13	32.29KB	Share
CDX	Appendix 3B		03/12/13	328.81KB	Share
CDX +ALF	Change in substantial holding from ALF		02/12/13	41.67KB	Share
CDX	ASX Price Query & Response	PRICE SENSITIVE	12/11/13	172.08KB	Share
CDX	Change of Director's Interest Notice		08/11/13	210.36KB	Share
CDX	Change of Director's Interest Notice		05/11/13	210.38KB	Share
CDX	Appendix 3B		05/11/13	329.14KB	Share
CDX	Results of Meeting		01/11/13	70.88KB	Share
CDX	Appendix 3B		31/10/13	335.34KB	Share
CDX	Chairmans address to shareholders		31/10/13	115.41KB	Share
CDX	Investor presentation		28/10/13	1.53MB	Share
CDX	US$0.6 million new pharmaceutical trial contract	PRICE SENSITIVE	28/10/13	99.62KB	Share
CDX	Mexico registration update		25/10/13	103.12KB	Share
CDX	Appendix 4C - quarterly	PRICE SENSITIVE	23/10/13	237.08KB	Share
CDX	Change of Director's Interest Notice x 4		22/10/13	256.99KB	Share
CDX +ALF	Change in substantial holding from ALF		09/10/13	44.11KB	Share
CDX	XCEL rated excellent according to European guidelines		02/10/13	118.56KB	Share
CDX	Appendix 3B		01/10/13	328.45KB	Share
CDX	Change of Director's Interest Notice		30/09/13	245.25KB	Share
CDX	Annual Report to shareholders		30/09/13	1.85MB	Share
CDX	Notice of Annual General Meeting/Proxy Form		30/09/13	405.29KB	Share
CDX	Aust study demonstrates the benefits of measuring central BP	PRICE SENSITIVE	26/09/13	35.59KB	Share
CDX	SphygmoCor XCEL approved for sale in Mexico	PRICE SENSITIVE	04/09/13	33.36KB	Share
CDX	Preliminary Final Report & Annual Accounts	PRICE SENSITIVE	30/08/13	483.09KB	Share
CDX	AtCor reports $2.7 million maiden profit for FY2013		30/08/13	34.65KB	Share
CDX	Half Yearly Report and Accounts	PRICE SENSITIVE	30/08/13	483.14KB	Share
CDX	Appendix 3B		22/08/13	176.09KB	Share
CDX	SphygmoCor XCEL approved for sale in Republic of Korea	PRICE SENSITIVE	07/08/13	33.5KB	Share
CDX	Seminal study for central pressures in clinical practice	PRICE SENSITIVE	01/08/13	35.14KB	Share
CDX	Investor Presentation		22/07/13	855.19KB	Share
CDX	AtCor to report full year maiden profit	PRICE SENSITIVE	22/07/13	43.88KB	Share
CDX	Appendix 4C - quarterly	PRICE SENSITIVE	22/07/13	176.9KB	Share
CDX	Patent granted in Europe	PRICE SENSITIVE	15/07/13	18.79KB	Share
CDX	Shareholder Update		23/05/13	1.18MB	Share

CDX Appointment of new Director
14/10/15		28.59KB	Share
CDX Annual Report to shareholders
13/10/15		12.61MB	Share
CDX Appendix 4G/Corporate Governance Statement
13/10/15		719.51KB	Share
CDX Notice of Annual General Meeting/Proxy Form
13/10/15		242.07KB	Share
CDX Appendix 3B
16/09/15		133.57KB	Share
CDX Ceasing to be a substantial holder from OCP
21/08/15		114.04KB	Share
CDX App 4E / Full Year Statutory Accounts
20/08/15	PRICE SENSITIVE	723.79KB	Share
CDX Change in substantial holding
11/08/15		185.95KB	Share
CDX Change of Director's Interest Notice x 4
29/07/15		121.33KB	Share
CDX American Heart Assoc new statement on arterial stiffness
28/07/15		29.2KB	Share
CDX Top 20 securityholders
23/07/15		27.81KB	Share
CDX Appendix 3B
23/07/15		135.91KB	Share
CDX Rights issue update
21/07/15		25.02KB	Share
CDX Notice of despatch of rights issue documents
02/07/15		31.17KB	Share
CDX Rights offer booklet
01/07/15	PRICE SENSITIVE	105.91KB	Share
CDX Becoming a substantial holder from AEF
25/06/15		381.49KB	Share
CDX Letter to shareholders - rights issue
24/06/15		44.74KB	Share
CDX Appendix 3B
23/06/15		134.64KB	Share
CDX Cleansing notice
23/06/15		73.89KB	Share
CDX Letter to optionholders - rights issue
23/06/15		84.98KB	Share
CDX Appendix 3B - rights
18/06/15		153.89KB	Share
CDX Successful share placement and rights issue
17/06/15	PRICE SENSITIVE	33.54KB	Share
CDX Trading Halt
15/06/15	PRICE SENSITIVE	64.29KB	Share
CDX Expert panel guidelines for central waveform analysis
28/05/15	PRICE SENSITIVE	38.31KB	Share
CDX Investor presentation
04/05/15		653.03KB	Share
CDX CE Mark for Oscar 2 with SphygmoCor Inside
04/05/15	PRICE SENSITIVE	55.09KB	Share
CDX Appendix 3B
31/03/15		146.79KB	Share
CDX Appendix 3B
24/03/15		147.09KB	Share
CDX Appendix 3B
18/03/15		146.65KB	Share
CDX Change in substantial holding
13/03/15		207.96KB	Share
CDX Appendix 3B
12/03/15		146.69KB	Share
CDX Teleconference details
10/03/15		40.77KB	Share
CDX AMA accepts recommendation for category 1 CPT code
10/03/15	PRICE SENSITIVE	50.31KB	Share
CDX AtCor reports first half profit
23/02/15		34.09KB	Share
CDX Half Yearly Report and Accounts
23/02/15	PRICE SENSITIVE	279.99KB	Share
CDX Tax refund
22/01/15	PRICE SENSITIVE	24.53KB	Share
CDX +OCP Becoming a substantial holder from OCP
04/12/14		267.68KB	Share
CDX +OCP Becoming a substantial holder from OCP
04/12/14		263.33KB	Share
CDX Appendix 3B
03/12/14		146.87KB	Share
CDX Cleansing statement
28/11/14		27.79KB	Share
CDX +OCP Successful share placement
28/11/14	PRICE SENSITIVE	26.17KB	Share
CDX Trading Halt
27/11/14	PRICE SENSITIVE	51.72KB	Share
CDX Results of Meeting
31/10/14		34.31KB	Share
CDX Chairmans address to AGM
31/10/14		89.84KB	Share
CDX Investor presentation
24/10/14		986.04KB	Share
CDX SphygmoCor selected for US publicly funded study
07/10/14	PRICE SENSITIVE	26.13KB	Share
CDX Annual Report to shareholders
30/09/14		1.13MB	Share
CDX Notice of Annual General Meeting/Proxy Form
30/09/14		641.19KB	Share
CDX Change in substantial holding
12/09/14		159.69KB	Share
CDX SphygmoCor selected for French Alzheimers trial
03/09/14	PRICE SENSITIVE	32.26KB	Share
CDX App 4E / Full Year Statutory Accounts
28/08/14	PRICE SENSITIVE	1.16MB	Share
CDX Market update
03/07/14	PRICE SENSITIVE	32.4KB	Share
CDX AtCor and SunTech launch innovative ABPM for Central BP
18/06/14	PRICE SENSITIVE	48.99KB	Share
CDX First SphygmoCor sales in China
02/06/14	PRICE SENSITIVE	29.56KB	Share
CDX Investor presentation
01/05/14		1.44MB	Share
CDX Patent grant in USA
16/04/14	PRICE SENSITIVE	35.76KB	Share
CDX Study shows improved outcomes from SphygmoCor guided therapy
03/04/14	PRICE SENSITIVE	39.06KB	Share
CDX Change in substantial holding
07/03/14		85.85KB	Share
CDX 1H FY2014 results
20/02/14		33.37KB	Share
CDX Half Yearly Report and Accounts
20/02/14	PRICE SENSITIVE	346.08KB	Share
CDX SphygmoCor XCEL approved for sale in Canada
30/01/14	PRICE SENSITIVE	104.91KB	Share
CDX +ALF Ceasing to be a substantial holder from ALF
14/01/14		16.57KB	Share
CDX SphygmoCor XCEL approved for sale in China
14/01/14	PRICE SENSITIVE	108.08KB	Share
CDX Market update
09/01/14	PRICE SENSITIVE	157.53KB	Share
CDX Appendix 3B
08/01/14		328.92KB	Share
CDX +ALF Change in substantial holding from ALF
06/01/14		43.93KB	Share
CDX Meta-analysis finds improved cardiovascular risk prediction
12/12/13		32.29KB	Share
CDX Appendix 3B
03/12/13		328.81KB	Share
CDX +ALF Change in substantial holding from ALF
02/12/13		41.67KB	Share
CDX ASX Price Query & Response
12/11/13	PRICE SENSITIVE	172.08KB	Share
CDX Change of Director's Interest Notice
08/11/13		210.36KB	Share
CDX Change of Director's Interest Notice
05/11/13		210.38KB	Share
CDX Appendix 3B
05/11/13		329.14KB	Share
CDX Results of Meeting
01/11/13		70.88KB	Share
CDX Appendix 3B
31/10/13		335.34KB	Share
CDX Chairmans address to shareholders
31/10/13		115.41KB	Share
CDX Investor presentation
28/10/13		1.53MB	Share
CDX US$0.6 million new pharmaceutical trial contract
28/10/13	PRICE SENSITIVE	99.62KB	Share
CDX Mexico registration update
25/10/13		103.12KB	Share
CDX Appendix 4C - quarterly
23/10/13	PRICE SENSITIVE	237.08KB	Share
CDX Change of Director's Interest Notice x 4
22/10/13		256.99KB	Share
CDX +ALF Change in substantial holding from ALF
09/10/13		44.11KB	Share
CDX XCEL rated excellent according to European guidelines
02/10/13		118.56KB	Share
CDX Appendix 3B
01/10/13		328.45KB	Share
CDX Change of Director's Interest Notice
30/09/13		245.25KB	Share
CDX Annual Report to shareholders
30/09/13		1.85MB	Share
CDX Notice of Annual General Meeting/Proxy Form
30/09/13		405.29KB	Share
CDX Aust study demonstrates the benefits of measuring central BP
26/09/13	PRICE SENSITIVE	35.59KB	Share
CDX SphygmoCor XCEL approved for sale in Mexico
04/09/13	PRICE SENSITIVE	33.36KB	Share
CDX Preliminary Final Report & Annual Accounts
30/08/13	PRICE SENSITIVE	483.09KB	Share
CDX AtCor reports $2.7 million maiden profit for FY2013
30/08/13		34.65KB	Share
CDX Half Yearly Report and Accounts
30/08/13	PRICE SENSITIVE	483.14KB	Share
CDX Appendix 3B
22/08/13		176.09KB	Share
CDX SphygmoCor XCEL approved for sale in Republic of Korea
07/08/13	PRICE SENSITIVE	33.5KB	Share
CDX Seminal study for central pressures in clinical practice
01/08/13	PRICE SENSITIVE	35.14KB	Share
CDX Investor Presentation
22/07/13		855.19KB	Share
CDX AtCor to report full year maiden profit
22/07/13	PRICE SENSITIVE	43.88KB	Share
CDX Appendix 4C - quarterly
22/07/13	PRICE SENSITIVE	176.9KB	Share
CDX Patent granted in Europe
15/07/13	PRICE SENSITIVE	18.79KB	Share
CDX Shareholder Update
23/05/13		1.18MB	Share

REFRESH

First 4 5 6 7 8

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 3.2¢		Change -0.004(11.1%)		Mkt cap ! $17.60M

Open	High	Low	Value	Volume
3.2¢	3.2¢	3.2¢	$6.593K	206.0K

Buyers (Bids)

No.	Vol.	Price($)
2	195000	3.1¢

Sellers (Offers)

Price($)	Vol.	No.
3.3¢	100000	1

View Market Depth

No.	Vol.	Price($)
2	195000	0.031
7	672138	0.030
1	75000	0.029
2	275000	0.028
2	325000	0.027

Price($)	Vol.	No.
0.033	100000	1
0.034	100000	1
0.036	71197	1
0.037	500000	1
0.038	580000	1

Last trade - 13.09pm 11/08/2025 (20 minute delay)

CDX (ASX) Chart

CARDIEX LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories